We are hereby submitting the Finanical Result under Regulations 33 of SEBI(LODR) Regulations, 2015 for the quarter ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharpline Broadcast reported a sharp turnaround in Q3 FY26 (quarter ended 31 Dec 2025). Standalone revenue from operations nearly doubled to ₹2,052.10 lakhs from ₹1,041.23 lakhs a year ago. The company swung from a loss of ₹27.85 lakhs in Q3 last year to a profit of ₹755.55 lakhs, with EPS of ₹4.50 versus negative ₹0.17. On a consolidated basis, revenue grew to ₹2,195.19 lakhs from ₹1,102.64 lakhs, with a profit after tax of ₹785.46 lakhs (vs a loss of ₹40.51 lakhs). For the nine months ended December 2025, consolidated revenue rose to ₹7,244 lakhs from ₹2,634 lakhs, and the company reported a profit of ₹341.81 lakhs versus a loss of ₹496.92 lakhs in the prior-year period. Segment data shows broadcasting as the main revenue driver, with the new medicine segment also contributing. Statutory auditors (BAS & Co LLP) issued a clean limited review report with no qualifications.
Strong quarter with a clear swing back to profitability and near-doubling of revenue is likely to be viewed positively by investors and could lift sentiment on this small-cap stock. Investors should watch whether the new medicine segment sustains its growth and whether the high finance and depreciation costs remain manageable.